Larimar Therapeutics (LRMR) EBIT (2013 - 2026)
Larimar Therapeutics (LRMR) recorded EBIT of -$34.35 million in Q2 2026, compared with -$27.79 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) EBIT (2013 - 2026) Analysis & Trends
On a TTM basis, Larimar Therapeutics' EBIT came in at -$175.66 million as of Jun 30, 2026; for FY2025, it came in at -$172.5 million.
- Across earlier years, EBIT came in at -$90.89 million in FY2024, -$41.76 million in FY2023, -$36.53 million in FY2022 and -$50.47 million in FY2021.
- Quarterly EBIT has ranged from -$64.02 million in Q4 2025 to -$7.64 million in Q1 2023 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Larimar Therapeutics | 279.45 Mn | -389.49 Mn | - | -34.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.35 Mn |
| Mar 31, 2026 | -31.12 Mn |
| Dec 31, 2025 | -64.02 Mn |
| Sep 30, 2025 | -49.50 Mn |
| Jun 30, 2025 | -27.79 Mn |
| Mar 31, 2025 | -31.19 Mn |
| Dec 31, 2024 | -31.29 Mn |
| Sep 30, 2024 | -18.26 Mn |
| Jun 30, 2024 | -24.60 Mn |
| Mar 31, 2024 | -16.73 Mn |
| Dec 31, 2023 | -14.16 Mn |
| Sep 30, 2023 | -10.34 Mn |
| Jun 30, 2023 | -9.62 Mn |
| Mar 31, 2023 | -7.64 Mn |
| Dec 31, 2022 | -10.44 Mn |
| Sep 30, 2022 | -8.51 Mn |
| Jun 30, 2022 | -8.69 Mn |
| Mar 31, 2022 | -8.89 Mn |
| Dec 31, 2021 | -9.09 Mn |
| Sep 30, 2021 | -16.73 Mn |
API Access
Larimar Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();